Understanding the molecular mechanisms by which diet and exercise regulate disease has the potential to help identify new treatments. In their recent study, Chakraborty et al. (Cell Reports 2018;25:677-689) discovered that supplementation with a metabolic precursor produced β-hydroxybutyrate (BHB), counteracting the pathological effects of high-salt diet-induced hypertension, suggesting a new treatment modality.
Keywords: 1,3-butanediol; beta-hydroxybutyrate; hypertension; inflammasome; ketone; kidney disease.
Copyright © 2019 Elsevier Ltd. All rights reserved.